Recruiting
Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
NCT05453682
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea